Metatron (MRNJ) Announces CBD/Marijuana Cryptocurrency payment apps and the release of a New Class of Preferred Shares
DOVER, Del., Feb. 13, 2018 (GLOBE NEWSWIRE) --
via OTC PR WIRE—Metatron, Inc. (OTC:MRNJ), a pioneer of releasing Marijuana, Secure Chat and related apps announces an update of the Cannaboids app on iTunes and Google Play. This release includes new CBD products and transaction services for consumers and dispensaries.
Metatron has developed over 2000 apps for top tier clients with millions in sales and downloads in the health and wellness field, and at one time had more apps in the top 20 lifestyle category on iTunes than any other company. We also recently released Vaporized, the first peer to peer secure chat app.
Metatron has begun their capital raise to support the expansion and development of its apps and other projects by selling for a limited time its Series B preferred shares which are reverse split immune and we do accept Bitcoin and most major crypto currencies for qualified investors.
California has fully legalized marijuana and Canada, which has allowed medical marijuana for the past decade, will legalize recreational marijuana by the summer of 2018, according to the Canadian Prime Minister. In the U.S., 29 states including the District of Columbia, Guam and Puerto Rico offer medical marijuana programs, with 19 more states allowing limited access to marijuana-related products.
While legal cannabis already represents a multi-billion-dollar industry, most cannabis companies cannot open bank accounts, engage POS systems and accept credit card payments. As a result, the nascent industry has been stalled by the need to use cash as the main transaction medium until recently with or peer to peer transaction app BitWeed.
Blockchain technology can offer an important tool to allow the cannabis industry to prosper. Working with cash proves to be very inconvenient, as businesses are restricted from making large bank deposits, they are also unable to make online payments, expand supplier networks, and provide financial transaction transparency and security.
The update of this application, will give the company multiple advantages at ensuring the companies the ability to transact and service their customers.
"Cannabidiol (CBD) can help treat seizures, can reduce anxiety and paranoia, and can counteract the "high" caused by THC." Cancer.org
"More recently, scientists reported that THC and other cannabinoids such as CBD slow growth and/or cause death in certain types of cancer cells growing in lab dishes. Some animal studies also suggest certain cannabinoids may slow growth and reduce spread of some forms of cancer." Cancer.org
"I was open for anything at that point to try. And once I tried it and was consistent on CBD, that's when I realized, 'Wow, this stuff works.'" Jake Plummer, Former Denver Broncos starting quarterback, CBSnews.com
The NIH supports a broad portfolio of research on cannabinoids and the endocannabinoid system.
People interested, can view and download our current live apps focused on health and wellness, cannabis, crypto and secure message encryption by visiting the app stores below.
Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc
In Other News:
Tiffany Dehen submitted her second amended complaint to the Southern District of California, please visit her site http://TiffanyDehen.com to support her right to freedom of speech without intimidation and for the safety of women on college campuses. This case has far reaching implications and we suggest all customers and shareholders take a look.
Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company's operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's need for additional financing, which is not assured and which may result in dilution of shareholders, the company's status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron retained Global Discovery Group Inc. for $30,500 for consulting services, CSC Partners for $1,500, Bas1 for $2,501 and the company retained Pacific Equity Alliance LLC by issuing Integrative Business Alliance LLC 100m rule 144 for 1 year consulting services. Metatron does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
Metatron, Inc. 302-861-0431
News Provided by GlobeNewswire
© 2017 GlobeNewswire, Inc. All Rights Reserved